These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34378353)

  • 1. The Transcription Factor SUB1 Is a Master Regulator of the Macrophage TLR Response in Atherosclerosis.
    Huang R; Hu Z; Chen X; Cao Y; Li H; Zhang H; Li Y; Liang L; Feng Y; Wang Y; Su W; Kong Z; Melgiri ND; Jiang L; Li X; Du J; Chen Y
    Adv Sci (Weinh); 2021 Oct; 8(19):e2004162. PubMed ID: 34378353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.
    Yvan-Charvet L; Welch C; Pagler TA; Ranalletta M; Lamkanfi M; Han S; Ishibashi M; Li R; Wang N; Tall AR
    Circulation; 2008 Oct; 118(18):1837-47. PubMed ID: 18852364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.
    Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV
    J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.
    Cheng XW; Song H; Sasaki T; Hu L; Inoue A; Bando YK; Shi GP; Kuzuya M; Okumura K; Murohara T
    Hypertension; 2011 May; 57(5):981-9. PubMed ID: 21464389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
    Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
    Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
    Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
    Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages.
    Martinon F; Chen X; Lee AH; Glimcher LH
    Nat Immunol; 2010 May; 11(5):411-8. PubMed ID: 20351694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
    Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
    J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling.
    Liu B; Zhang N; Liu Z; Fu Y; Feng S; Wang S; Cao Y; Li D; Liang D; Li F; Song X; Yang Z
    Mol Cell Biochem; 2013 Jun; 378(1-2):183-93. PubMed ID: 23483427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K2 can suppress the expression of Toll-like receptor 2 (TLR2) and TLR4, and inhibit calcification of aortic intima in ApoE
    Wang Z; Wang Z; Zhu J; Long X; Yan J
    Vascular; 2018 Feb; 26(1):18-26. PubMed ID: 28587577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice.
    Higashimori M; Tatro JB; Moore KJ; Mendelsohn ME; Galper JB; Beasley D
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):50-7. PubMed ID: 20966403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4/MyD88/NF-κB pathway regulation.
    Li Y; Zhang L; Ren P; Yang Y; Li S; Qin X; Zhang M; Zhou M; Liu W
    Phytomedicine; 2021 Dec; 93():153812. PubMed ID: 34753029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.
    Schoneveld AH; Hoefer I; Sluijter JP; Laman JD; de Kleijn DP; Pasterkamp G
    Atherosclerosis; 2008 Mar; 197(1):95-104. PubMed ID: 17888930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
    Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G
    Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.